Search Results
EMA regulation of CAR T-cell therapy
Regulatory qualification for the EBMT patient registry for CAR T-cell therapy
Patient perspectives of CAR T-cell regulation
The EMA's PRIority MEdicines (PRIME) scheme
Regulatory and commercialization challenges with CAR T-cell therapy
Regulatory Landscape for CAR T-cell Therapy
The importance of the European Medicines Agency in CAR-T development
EIC – EMA Info Day: Regulatory support for the development of innovative medicines and technologies
Regulation of MRD in CLL: FDA and EMA
The EMA perspective on drug approval process in the era of precision medicine
The regulatory process for CAR-T in Europe: EBMT registry & GoCART
EMA initiatives on registries
